Neuromodulation for treatment-resistant depression: Functional network targets contributing to antidepressive outcomes

被引:6
|
作者
Idlett-Ali, Shaquia L. [1 ]
Salazar, Claudia A. [2 ]
Bell, Marcus S. [2 ]
Short, E. Baron [3 ]
Rowland, Nathan C. [2 ]
机构
[1] Univ Colorado Anschutz Med Campus, Dept Neurosurg, Aurora, CO 80045 USA
[2] Med Univ South Carolina, Dept Neurosurg, Charleston, SC USA
[3] Med Univ South Carolina, Dept Psychiat & Behav Sci, Charleston, SC USA
来源
关键词
deep brain stimulation; epidural cortical stimulation; neuromodulation; transcranial magnetic stimulation (repetitive); salience network; treatment-resistant depression; electroconvulsive therapy; TRANSCRANIAL MAGNETIC STIMULATION; DEEP BRAIN-STIMULATION; DEFAULT-MODE NETWORK; VAGUS NERVE-STIMULATION; VENTRAL CAPSULE/VENTRAL STRIATUM; DORSOLATERAL PREFRONTAL CORTEX; EPIDURAL CORTICAL STIMULATION; MAJOR DEPRESSION; CINGULATE CORTEX; SALIENCE NETWORK;
D O I
10.3389/fnhum.2023.1125074
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Non-invasive brain stimulation is designed to target accessible brain regions that underlie many psychiatric disorders. One such method, transcranial magnetic stimulation (TMS), is commonly used in patients with treatment-resistant depression (TRD). However, for non-responders, the choice of an alternative therapy is unclear and often decided empirically without detailed knowledge of precise circuit dysfunction. This is also true of invasive therapies, such as deep brain stimulation (DBS), in which responses in TRD patients are linked to circuit activity that varies in each individual. If the functional networks affected by these approaches were better understood, a theoretical basis for selection of interventions could be developed to guide psychiatric treatment pathways. The mechanistic understanding of TMS is that it promotes long-term potentiation of cortical targets, such as dorsolateral prefrontal cortex (DLPFC), which are attenuated in depression. DLPFC is highly interconnected with other networks related to mood and cognition, thus TMS likely alters activity remote from DLPFC, such as in the central executive, salience and default mode networks. When deeper structures such as subcallosal cingulate cortex (SCC) are targeted using DBS for TRD, response efficacy has depended on proximity to white matter pathways that similarly engage emotion regulation and reward. Many have begun to question whether these networks, targeted by different modalities, overlap or are, in fact, the same. A major goal of current functional and structural imaging in patients with TRD is to elucidate neuromodulatory effects on the aforementioned networks so that treatment of intractable psychiatric conditions may become more predictable and targeted using the optimal technique with fewer iterations. Here, we describe several therapeutic approaches to TRD and review clinical studies of functional imaging and tractography that identify the diverse loci of modulation. We discuss differentiating factors associated with responders and non-responders to these stimulation modalities, with a focus on mechanisms of action for non-invasive and intracranial stimulation modalities. We advance the hypothesis that non-invasive and invasive neuromodulation approaches for TRD are likely impacting shared networks and critical nodes important for alleviating symptoms associated with this disorder. We close by describing a therapeutic framework that leverages personalized connectome-guided target identification for a stepwise neuromodulation paradigm.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Neuromodulation and treatment-resistant depression: Promises and pitfalls
    Mallet, L.
    Aouizerate, B.
    Domenech, P.
    Palm, U.
    Schlaepfer, T.
    Baeken, C.
    [J]. EUROPEAN PSYCHIATRY, 2018, 48 : S242 - S243
  • [2] Immune disturbances in treatment-resistant depression: Modulation by antidepressive treatments
    Maes, M
    Vandoolaeghe, E
    VanHunsel, F
    Bril, T
    Demedts, P
    Wauters, A
    Neels, H
    [J]. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 1997, 12 (02) : 153 - 162
  • [3] Identifying 'paradigm failures' contributing to treatment-resistant depression
    Parker, GB
    Malhi, GS
    Crawford, JG
    Thase, ME
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2005, 87 (2-3) : 185 - 191
  • [4] Closed-loop neuromodulation in an individual with treatment-resistant depression
    Katherine W. Scangos
    Ankit N. Khambhati
    Patrick M. Daly
    Ghassan S. Makhoul
    Leo P. Sugrue
    Hashem Zamanian
    Tony X. Liu
    Vikram R. Rao
    Kristin K. Sellers
    Heather E. Dawes
    Philip A. Starr
    Andrew D. Krystal
    Edward F. Chang
    [J]. Nature Medicine, 2021, 27 : 1696 - 1700
  • [5] Neuromodulation-based approaches to treatment-resistant bipolar depression
    Vasile, Daniel
    Vasiliu, Octavian
    Vasiliu, Diana
    Bumbu, Gheorghe A.
    [J]. BIPOLAR DISORDERS, 2021, 23 : 89 - 89
  • [6] Neuropsychologic effects of neuromodulation techniques for treatment-resistant depression: A review
    Moreines, Jared L.
    McClintock, Shawn M.
    Holtzheimer, Paul E.
    [J]. BRAIN STIMULATION, 2011, 4 (01) : 17 - 27
  • [7] Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression
    Cole, Eleanor J.
    Stimpson, Katy H.
    Bentzley, Brandon S.
    Gulser, Merve
    Cherian, Kirsten
    Tischler, Claudia
    Nejad, Romina
    Pankow, Heather
    Choi, Elizabeth
    Aaron, Haley
    Espil, Flint M.
    Pannu, Jaspreet
    Xiao, Xiaoqian
    Duvio, Dalton
    Solvason, Hugh B.
    Hawkins, Jessica
    Guerra, Austin
    Jo, Booil
    Raj, Kristin S.
    Phillips, Angela L.
    Barmak, Fahim
    Bishop, James H.
    Coetzee, John P.
    DeBattista, Charles
    Keller, Jennifer
    Schatzberg, Alan F.
    Sudheimer, Keith D.
    Williams, Nolan R.
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2020, 177 (08): : 716 - 726
  • [8] EXPERIENCE OF STANFORD NEUROMODULATION THERAPY IN PATIENTS WITH TREATMENT-RESISTANT DEPRESSION
    Poydasheva, A. G.
    Bakulin, I. S.
    Sinitsyn, D. O.
    Zabirova, A. H.
    Suponeva, N. A.
    Maslenikov, N., V
    Tsukarzi, E. E.
    Mosolo, S. N.
    Piradov, M. A.
    [J]. BULLETIN OF RUSSIAN STATE MEDICAL UNIVERSITY, 2022, (04): : 31 - 37
  • [9] Stanford neuromodulation therapy for treatment-resistant depression: a systematic review
    Lan, Xian-Jun
    Cai, Dong-Bin
    Liu, Qi-Man
    Qin, Zhen-Juan
    Pridmore, Saxby
    Zheng, Wei
    Xiang, Yu-Tao
    [J]. FRONTIERS IN PSYCHIATRY, 2023, 14
  • [10] Closed-loop neuromodulation in an individual with treatment-resistant depression
    Scangos, Katherine W.
    Khambhati, Ankit N.
    Daly, Patrick M.
    Makhoul, Ghassan S.
    Sugrue, Leo P.
    Zamanian, Hashem
    Liu, Tony X.
    Rao, Vikram R.
    Sellers, Kristin K.
    Dawes, Heather E.
    Starr, Philip A.
    Krystal, Andrew D.
    Chang, Edward F.
    [J]. NATURE MEDICINE, 2021, 27 (10) : 1696 - +